SSW08: Pycnogenol Reduces CVD Risk Factors in Diabetics

Ronald Watson, Ph.D., reviewed results of a study on the effects of Pycnogenol® supplementation on the reduction of cardiovascular risk factors in subjects with type 2 diabetes. Subjects with both type 2 diabetes and mild to moderate hypertension were randomly assigned to receive either Pycnogenol or placebo for 12 weeks. Results showed that Pycnogenol lowers blood glucose, normalizes blood pressure, improves blood circulation, lowers LDL cholesterol and improves kidney function. Results “confirm the hypotheses that Pycnogenol improves diabetes control, reduces antihypertensive medicine use medicine use, and may favor a reduction in cardiovascular disease risk in individuals with type 2 diabetes,” Watson said.